Dr. Egrari was vaccinated on December 30, 2020. The rest of the staff at EPSC was vaccinated in the first week of January 2021. Our anesthesia staff has also been fully vaccinated. We strongly believe in the efficacy and safety of the vaccine.

Here are two definitive articles that demonstrate the initial evaluation of the vaccine published in the New England Journal of Medicine:

Safety And Efficacy Of The BNT162B2 MRNA Covid-19 Vaccine (NEJM)

The Pfizer/BioNTech SARS-CoV-2 spike protein mRNA vaccine was 95% efficacious in preventing symptomatic COVID-19 after two doses. Similar vaccine efficacy was observed by age, sex, race, ethnicity, baseline body-mass index, and the presence of coexisting conditions. There were no serious safety concerns in the more than 20,000 patients in the treatment arm.

Efficacy And Safety Of The MRNA-1273 SARS-COV-2 Vaccine (NEJM)

The Moderna vaccine showed 94.1% efficacy in preventing Covid-19 IllnessAside from transient local reaction, no safety concerns were identified in more than 15,000 patients who were in the treatment arm.
To find a location for vaccination please click here.

Background media
Contact us media

Terms & Conditions Privacy Policy Sitemap

© Egrari. All Rights Reserved.

Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at (425) 827-7878.
Contact Us